An observational study in Preeclampsia, sponsored by Oslo University Hospital. Completed. Open to female participants aged 20 Years to 43 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-07-06.
Sponsored by Oslo University Hospital · Observational
The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.
903 studies on the registry are indexed under Pre-Eclampsia; 240 are open to participants now.
This study's enrollment of 129 is below the median of 160 across 389 observational studies indexed under Pre-Eclampsia.
Browse Pre-Eclampsia studies →Oslo University Hospital is the lead sponsor of 830 studies on the registry; 146 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Case-control study consisting of 43 women developping preeclampsia and 86 women not developping this disorder. All were of Caucasian origin and were nulliparous.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No study locations are listed for this record.
This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.